RAGE and amyloid beta interactions: Atomic force microscopy and molecular modeling

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1741, Issue 1-2, 2005, Pages 199-205

  Chaney, Michael O ^a   Stine, W Blaine ^b   Kokjohn, Tyler A ^c   Kuo, Yu Min ^d   Esh, Chera ^e   Rahman, Afroza ^e   Luehrs, Dean C ^e   Schmidt, Ann Marie ^a   Stern, David ^f   Yan, Shi Du ^a   Roher, Alex E ^e  

^a College of Physicians and Surgeons ^*  (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c MIDWESTERN UNIVERSITY   (United States)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e SUN HEALTH RESEARCH INSTITUTE   (United States)

^f MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Alzheimer's disease; Atomic force microscopy; IgG; Molecular modeling; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN;

ALGORITHM; AMINO TERMINAL SEQUENCE; ARTICLE; ATOMIC FORCE MICROSCOPY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; INCUBATION TIME; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN POLYMERIZATION; PROTEIN PROTEIN INTERACTION;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; ANTIGENS, NEOPLASM; DIMERIZATION; DISULFIDES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOGLOBULIN G; MICROSCOPY, ATOMIC FORCE; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, MOLECULAR; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, IMMUNOLOGIC; SOLUBILITY;

RUMEX;

EID: 20444462454     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2005.03.014     Document Type: Article

References (55)

1. Y. Verdier, and B. Penke Binding sites of amyloid β-peptide in cell plasma membrane and implications for Alzheimer's disease Curr. Protein Pept. Sci. 5 2004 19 31
2. S.D. Yan, X. Chen, J. Fu, M. Chen, H. Zhu, A. Roher, J. Slattery, L. Zhao, M. Nagashima, J. Morser, A. Migheli, P. Nawroth, D. Stern, and A.M. Schmidt RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease Nature 382 1996 685 691
3. S.D. Yan, H. Zhu, J. Fu, S.F. Yan, A. Roher, W.W. Tourtellotte, T. Rajavashisth, X. Chen, G.C. Godman, D. Stern, and A.M. Schmidt Amyloid-β peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 94 1997 5296 5301
4. J.B. Mackic, M. Stins, J.G. McComb, M. Calero, J. Ghiso, K.S. Kim, S.D. Yan, D. Stern, A.M. Schmidt, B. Frangione, and B. Zlokovic Human blood-brain barrier receptors for Alzheimer's amyloid-β 1-40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer J. Clin. Invest. 102 1998 734 743
5. R. Giri, Y. Shen, M. Stins, S.D. Yan, A.M. Schmidt, D. Stern, K.S. Kim, B. Zlokovic, and V.K. Kalra β-Amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1 Am. J. Physiol.: Cell Physiol. 279 2000 C1772 C1781
6. N. Sasaki, M. Takeuchi, H. Chowei, S. Kikuchi, Y. Hayashi, N. Nakano, H. Ikeda, S. Yamagishi, T. Kitamoto, T. Saito, and Z. Makita Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeld-Jakob disease with prion plaques Neurosci. Lett. 326 2002 117 120
7. A.M. Schmidt, S.D. Yan, S.F. Yan, and D.M. Stern The biology of the receptor for advanced glycation end products and its ligands Biochem. Biophys. Acta 1498 2000 99 111
8. L.G. Bucciarelli, T. Wendt, L. Rong, E. Lalla, M.A. Hofmann, M.T. Goova, A. Taguchi, S.F. Yan, S.D. Yan, D.M. Stern, and A.M. Schmidt RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease Cell. Mol. Life Sci. 59 2002 1117 1128
9. M. Neeper, A.M. Schmidt, J. Brett, S.D. Yan, F. Wang, Y.C.E. Pan, K. Elliston, D. Stern, and A. Shaw Cloning and expression of a cell surface receptor for advanced glycosation end products of proteins J. Biol. Chem. 267 1992 14998 15004
10. A.M. Schmidt, O. Hori, J. Brett, S.D. Yan, J.L. Wautier, and D. Stern Cellular receptors for advanced glycation end products: implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions Arterioscler. Thromb. 14 1994 1521 1528
11. A.M. Schmidt, R. Mora, R. Cao, S.D. Yan, J. Brett, R. Ramakrishnan, T.C. Tsang, M. Simionescu, and D. Stern The endothelial cell binding site for advanced glycation end products consists of a complex: an integral membrane protein and a lacto-ferrin-like polypeptide J. Biol. Chem. 269 1994 9882 9888
12. A.E. Roher, J.D. Lowenstein, S. Clarke, A.S. Woods, R.J. Cotter, E. Gowing, and M. Ball β-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: Implications for the pathology of Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 90 1993 10836 10840
13. A.E. Roher, J.D. Lowenson, S. Clarke, C. Wolkow, R. Wang, R.J. Cotter, I.M. Reardon, H.A. Zurcher-Neely, R.L. Heinrikson, M.J. Ball, and B.D. Greenberg Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease J. Biol. Chem. 268 1993 3072 3083
14. R. Deane, S.D. Yan, R.K. Submamaryan, B. LaRue, S. Jovanovic, E. Hogg, D. Welch, L. Manness, C. Lin, J. Yu, H. Zhu, J. Ghiso, B. Frangione, A. Stern, A.M. Schmidt, D.L. Armstrong, B. Arnold, B. Liliensiek, P. Nawroth, F. Hofman, M. Kindy, D. Stern, and B. Zlokovic RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain Nat. Med. 9 2003 907 913
15. W.R. Pearson Effective protein sequence comparison R.F. Doolittle Methods in Enzymology 1996 Academic Press San Diego 227 258
16. M. Machius, P. Cianga, J. Deisenhofer, and E.S. Ward Crystal structure of a T cell receptor Vα11 (AV11S5) domain: new canonical forms for the first and second complementary determining regions J. Mol. Biol. 310 2001 689 698
17. M.O. Chaney, S.D. Webster, Y.M. Kuo, and A.E. Roher Molecular modeling of the Aβ-42 peptide from Alzheimer's disease Protein Eng. 11 1998 761 767
18. C. Hilbich, B. Kisters-Woike, J. Reed, C.L. Masters, and K. Beyreuther Aggregation and secondary structure of synthetic amyloid β A4 peptides of Alzheimer's disease J. Mol. Biol. 218 1991 149 163
19. H. Edelsbrunner, M. Facello, R. Fu, and J. Liang Measuring proteins and voids in proteins Proceedings of the 28th Hawaii International Conference on Systems Science 1995 226 264
20. M. Levitt Accurate modeling of protein conformation by automatic segment matching J. Mol. Biol. 226 1992 507 533
21. T. Fechteler, U. Dengler, and D. Schomburg Prediction of protein three-dimensional structures in insertion and deletion regions: a procedure for searching data bases of representative protein fragments using geometric scoring criteria J. Mol. Biol. 253 1995 114 131
22. G.N. Ramachandran, and V. Sasisekharan Conformation of polypeptides and proteins Adv. Protein Chem. 23 1968 283 438
23. L.F. Lue, D.G. Walker, L. Brachova, T.G. Beach, J. Rogers, A.M. Schmidt, D.M. Stern, and S.D. Yan Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism Exp. Neurol. 171 2001 29 45
24. S.D. Yan, D. Stern, M.D. Kane, Y.M. Kuo, H.C. Lampert, and A.E. Roher RAGE-Aβ interactions in the pathophysiology of Alzheimer's disease Restor. Neurol. Neurosci. 12 1998 167 173
25. T. Kislinger, C. Fu, B. Huber, W. Qu, A. Taguchi, S.D. Yan, M. Hofmann, S.F. Yan, M. Pischetsrieder, D. Stern, and A.M. Schmidt N(ε)- (carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression J. Biol. Chem. 274 1999 31740 31749
26. B.I. Hudson, L.G. Bucciarelli, T. Wendt, T. Sakaguchi, E. Lalla, W. Qu, Y. Lu, L. Lee, D.M. Stern, Y. Naka, R. Ramasamy, S.D. Yan, S.F. Yan, V. D'Agati, and A.M. Schmidt Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders Arch. Biochem. Biophys. 419 2003 80 88
27. J. Miura, Y. Uchigata, Y. Yamamoto, M. Takeuchi, S. Sakurai, T. Watanabe, H. Yonekura, S. Yamagishi, Z. Makita, A. Sato, Y. Omori, H. Yamamoto, and Y. Iwamoto AGE down-regulation of monocyte RAGE expression and its association with diabetic complications in type 1 diabetes J. Diabetes Complicat. 18 2004 53 59
28. M. Morcos, A.A.R. Sayed, A. Bierhaus, B. Yard, R. Waldherr, W. Merz, I. Kloeting, E. Schleicher, S. Mentz, R.F.A. el Baki, H. Tritschler, M. Kasper, V. Schwenger, A. Hamann, K.A. Dugi, A.M. Schmidt, D. Stern, R. Ziegler, H.U. Haering, M. Andrassy, F. van der Woude, and P.P. Nawroth Activation of tubular epithelial cells in diabetic nephropathy Diabetes 51 2002 3532 3544
29. C.H. Yeh, L. Sturgis, J. Haidacher, X.N. Zhang, S.J. Sherwood, R.J. Bjercke, O. Juhasz, M.T. Crow, R.G. Tilton, and L. Denner Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-κB transcriptional activation and cytokine secretion Diabetes 50 2001 1495 1504
30. K.M. Haslbeck, A. Bierhaus, S. Erwin, A. Kirchner, P. Nawroth, U. Schlotzer, B. Neundorfer, and D. Heuss Receptor for advanced glycation endproduct (RAGE)-mediated nuclear factor-κB activation in vasculitic neuropathy Muscle Nerve 29 2004 853 860
31. H.P. Hammes, H. Hoerauf, A. Alt, E. Schleicher, and J.T. Clausen N(ε)(carboxymethyl)lysin and the AGE receptor RAGE colocalize in age-related macular degeneration Invest. Ophthalmol. Visual. Sci. 40 1999 1855 1859
32. P. Malherbe, J.G. Richards, H. Gaillard, A. Thompson, C. Diener, A. Schuler, and G. Huber cDNA cloning of a novel secreted isoform of the human receptor for advanced glycation end products and characterization of cells co-expressing cell-surface scavenger receptors and Swedish mutant amyloid precursor protein Brain Res. Mol. Brain Res. 71 1999 159 170
33. R. Giri, S. Selvaraj, C.A. Miller, F. Hofman, S.D. Yan, D. Stern, B. Zlokovic, and V.K. Kalra Effect of endothelial cell polarity on β-amyloid-induced migration of monocytes across normal and AD endothelium Am. J. Physiol.: Cell Physiol. 283 2002 C895 C904
34. S. Mruthinti, W.D. Hill, S. Swamy-Mruthini, and J.J. Buccafusco Relationship between the induction of RAGE cell-surface antigen and the expression of amyloid binding sites J. Mol. Neurosci. 20 2003 223 232
35. S. Mruthinti, J.J. Buccafusco, W.D. Hill, J.L. Waller, T.W. Jackson, E.Y. Zamrini, and R.F. Schade Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Aβ and RAGE peptides Neurobiol. Aging 25 2004 1023 1032
36. J. McLaurin, and P.E. Fraser Effect of amino-acid substitutions on Alzheimer's amyloid-β peptide-glycosaminoglycan interactions Eur. J. Biochem. 267 2004 6353 6361
37. H. Potter The involvement of astrocytes and an acute phase response in the amyloid deposition of Alzheimer's disease Prog. Brain Res. 94 1992 447 458
38. J. Rogers, N.R. Cooper, S. Webster, J. Schultz, P.L. McGeer, S.D. Styren, W.H. Civin, L. Brachova, B. Bradt, P. Ward, and I. Lieberburg Complement activation by β-amyloid in Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 89 1992 10016 10020
39. M. Sadowski, J. Pankiewicz, H. Scholtzova, J.A. Ripellino, Y. Li, S.D. Schmidt, P.M. Mathews, J.D. Fryer, D.M. Holtzman, E.M. Sigurdsson, and T.A. Wisniewski Synthetic peptide blocking the apolipoprotein E/β-amyloid binding mitigates β-amyloid toxicity and fibril formation in vitro and reduces β-amyloid plaques in transgenic mice Am. J. Pathol. 165 2004 937 948
40. D. Giulian, L. Haverkamp, J. Yu, W. Karshin, D. Tom, J. Li, J. Kirkpatrick, Y.M. Kuo, and A.E. Roher Specific domains of β-amyloid from Alzheimer's plaque elicit neuron killing in human microglia J. Neurosci. 16 1996 6021 6037
41. D. Giulian, L.J. Haverkamp, J. Yu, W. Karshin, D. Tom, J. Li, A. Kazanskaia, J. Kirkpatrick, and A.E. Roher The HHQK domain of β-amyloid provides a structural basis for the immunopathology of Alzheimer's disease J. Biol. Chem. 273 1998 29719 29726
42. A.E. Roher, J. Baudry, M.O. Chaney, Y.M. Kuo, W.B. Stine, and M.R. Emmerling Oligomerization and fibril assembly of the amyloid-β protein Biochim. Biophys. Acta 1502 2000 31 43
43. A.I. Bush The metallobiology of Alzheimer's disease Trends Neurosci. 26 2003 207 214
44. D. Frenkel, O. Katz, and B. Solomon Immunization against Alzheimer's β-amyloid plaques via EFRH phage administration Proc. Natl. Acad. Sci. U. S. A. 97 2000 11455 11459
45. B. Solomon Immunological approach for the treatment of Alzheimer's disease J. Mol. Neurosci. 20 2003 283 286
46. H. Yamaguchi, S. Hirai, M. Morimatsu, M. Shoji, and Y. Harigaya Diffuse type of senile plaques in the brains of Alzheimer-type dementia Acta Neuropathol. (Berl) 77 1988 113 119
47. F. Tagliavini, G. Giaccone, B. Frangione, and O. Bugiani Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals Neurosci. Lett. 93 1988 191 196
48. E. Gowing, A.E. Roher, A.S. Woods, R.J. Cotter, M. Chaney, S.P. Little, and M.J. Ball Chemical characterization of Aβ 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease J. Biol. Chem. 269 1994 10987 10990
49. O. Bugiani, F. Tagliavini, G. Giaccone, L. Verga, K. el Hachimi, J.F. Foncin, and B. Frangione Diffuse senile plaques: amorphous or fibrous? Am. J. Pathol. 146 1995 777 779
50. E. Masliah, T.D. Terry, M. Mallory, M. Alford, and L.A. Hansen Diffuse plaques do not accentuate synapse loss in Alzheimer's disease Am. J. Pathol. 137 1990 1293 1297
51. S. Vogelgesang, E. Schroeder, L.C. Walker, J. Pahnke, A. Naubereit, R. Walther, D. Stausske, and R.W. Warzok Activated microglia do not mediate the early deposition of Aβ in carriers of the apolipoprotein Eε4 allele Clin. Neuropathol. 21 2002 99 106
52. L. Verga, B. Frangione, F. Tagliavini, G. Giaccone, A. Migheli, and O. Bugiani Alzheimer patients and Down patients: cerebral preamyloid deposits differ ultrastructurally and histochemically from the amyloid of senile plaques Neurosci. Lett. 105 1989 294 299
53. T. Ohgami, T. Kitamoto, R.W. Shin, Y. Kaneko, K. Ogomori, and J. Tateishi Increased senile plaques without microglia in Alzheimer's disease Acta Neuropathol. (Berl) 81 1991 242 247
54. H. Akiyama, H. Mori, T. Saido, H. Kondo, K. Ikeda, and P.L. McGreer Occurrence of the diffuse amyloid β-protein (Aβ) deposits with numerous Aβ-containing glial cells in the cerebral cortex of patients with Alzheimer's disease Glia 25 1999 324 331
55. S.E. Stoltzner, T.J. Grenfell, C. Mori, K.E. Wisniewski, T.M. Wisniewski, D.J. Selkoe, and C.A. Lemere Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease Am. J. Pathol. 156 2000 489 499